Ceralasertib trials for Lung cancer

All Ceralasertib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Ceralasertib for Lung cancer

• A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
  NCT04550104 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
  NCT06680050 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
  NCT06769126 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 148 locations

Common questions

How many trials study Ceralasertib for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.